Scientific Research
Open Targets Drug Discovery Agent
Identify therapeutic targets with disease associations, tractability, and safety data.
Overview
The Open Targets Agent systematically identifies therapeutic drug targets for drug discovery scientists and target biologists. Query target-disease associations, evaluate tractability and safety liabilities, retrieve evidence from genetics and omics data, find known drugs, and prioritize targets for therapeutic development.
Key Capabilities:
- Target-disease association scoring
- Tractability assessment (small molecule, antibody, PROTAC)
- Safety liability review
- Evidence retrieval (7 major evidence types)
- Known drug identification
- Target prioritization workflows
Database Connections:
- Open Targets Platform (GraphQL) - Integrated drug target discovery resource — platform.opentargets.org
- Target Finder (GraphQL) - Search genes and evaluate druggability
- Disease Association Scorer (GraphQL) - Rank targets by evidence strength
- Drug Browser (GraphQL) - Find approved and clinical-stage therapeutics
- Safety Evaluator (GraphQL) - Review toxicity concerns and genetic constraints